Medical racism, new Covid vaccines, & the resilience of Regeneron

By FYH News Team

Published on March 3, 2022

[ad_1]

How many Covid-19 vaccines does the world really need? What will it take to address inequality in American health care? And should people be nicer to Moderna?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss the latest news in Covid-19 vaccines, including data from Sanofi and GlaxoSmithKline, the future of Novavax, and what comes next for Moderna. Then, STAT’s Usha Lee McFarling joins us to talk about a groundbreaking investigation into racial and ethnic disparities in American medicine — and why almost nothing has changed in the 20 years since it was published.

For more on what we cover, here’s part one and part two of the “Unequal Treatment” series; here’s the latest on Covid-19 vaccines; here’s where you can watch “Augmented”; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.

Be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].

[ad_2]

Source link

Features

Download and distribute powerful vaccination QI resources for your community.

MCED tests use a simple blood draw to screen for many kinds of cancer at once.

FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.

Discover an honest look at our Medicare system.

ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.